Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 26, 2026
Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
LMP2A-The Other EBV Oncogene.
Journal: Current topics in microbiology and immunology
Published: October 07, 2025
CD8+ T-cell Antitumor Immunity via Human iNKT-DC Conjugates.
Journal: Cancer immunology research
Published: April 11, 2025
ob/ob obese mice promote tumorigenesis of endometrial cancer associated with Pten deficiency.
Journal: Endocrine-related cancer
Published: August 29, 2024
Epstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms.
Journal: Cell reports
Published: March 21, 2024
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
Journal: PLoS pathogens
Published: September 14, 2023
Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 08, 2023
EBV Reactivation from Latency Is a Degrading Experience for the Host.
Journal: Viruses
Published: February 07, 2023
Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
Journal: PLoS pathogens
Published: June 20, 2022
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
Journal: PLoS pathogens
Published: April 26, 2022
Last Updated: 09/26/2026